Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842426 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Lifestyle Interventions to Treat Elevated Cardiometabolic Risk in Primary Care
A Phase 2 study, sponsored by Palo Alto Medical Foundation.
- Completed
- Registry status
- Phase 2
- Development phase
- 241
- Enrollment target
NCT00842426: Completed Phase 2 study, sponsored by Palo Alto Medical Foundation.
NCT00842426 is a Phase 2 study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 241 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842426, a Phase 2 study, has completed, sponsored by Palo Alto Medical Foundation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 241 participants
- Enrollment target
Study Summary
The purpose of the E-LITE Study is to evaluate the feasibility and potential effectiveness of two lifestyle interventions in a community based primary care setting. The study aims to assess how changes in diet, exercise, and behavioral self-management affect weight and related risk factors for adults at risk for diabetes and cardiovascular disease.
Interventions
- BEHAVIORAL Self-management program (SM)
- BEHAVIORAL Care management program (CM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
What the finished NCT00842426 record still lists
NCT00842426 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% higher).
The record links to 0 conditions, and to 2 interventions - of which Self-management program (SM) is the first listed.
NCT00842426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00842426 about?
NCT00842426 is a clinical study titled "Evaluation of Lifestyle Interventions to Treat Elevated Cardiometabolic Risk in Primary Care". The purpose of the E-LITE Study is to evaluate the feasibility and potential effectiveness of two lifestyle interventions in a community based primary care setting. The study aims to assess how changes in diet, exercise, and behavioral self-management affect weight and related risk factors for adult...
What is the current status of trial NCT00842426?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 241 participants. The study started on 2009-06. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00842426?
The interventions under investigation include: Self-management program (SM) (BEHAVIORAL), Care management program (CM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00842426?
This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00842426's enrollment target sits among peer trials
241 239th of 2000 higher than 1,762 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia